342 related articles for article (PubMed ID: 35163550)
21. MicroRNAs targeting prostate cancer stem cells.
Fang YX; Chang YL; Gao WQ
Exp Biol Med (Maywood); 2015 Aug; 240(8):1071-8. PubMed ID: 25966983
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
23. Role of microRNAs in the development, prognosis and therapeutic response of patients with prostate cancer.
Ghafouri-Fard S; Shoorei H; Taheri M
Gene; 2020 Oct; 759():144995. PubMed ID: 32721477
[TBL] [Abstract][Full Text] [Related]
24. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
[TBL] [Abstract][Full Text] [Related]
25. Assessment of miR-98-5p, miR-152-3p, miR-326 and miR-4289 Expression as Biomarker for Prostate Cancer Diagnosis.
Moya L; Meijer J; Schubert S; Matin F; Batra J
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30845775
[TBL] [Abstract][Full Text] [Related]
26. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
[TBL] [Abstract][Full Text] [Related]
27. Up-regulated microRNA-143 in cancer stem cells differentiation promotes prostate cancer cells metastasis by modulating FNDC3B expression.
Fan X; Chen X; Deng W; Zhong G; Cai Q; Lin T
BMC Cancer; 2013 Feb; 13():61. PubMed ID: 23383988
[TBL] [Abstract][Full Text] [Related]
28. In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.
Cava C; Bertoli G; Colaprico A; Bontempi G; Mauri G; Castiglioni I
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29562723
[TBL] [Abstract][Full Text] [Related]
29. miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen.
Larne O; Östling P; Haflidadóttir BS; Hagman Z; Aakula A; Kohonen P; Kallioniemi O; Edsjö A; Bjartell A; Lilja H; Lundwall Å; Ceder Y
Eur Urol; 2015 Oct; 68(4):581-8. PubMed ID: 25556023
[TBL] [Abstract][Full Text] [Related]
30. MicroRNAs as biomarkers for early diagnosis, targeting and prognosis of prostate cancer.
Azani A; Omran SP; Ghasrsaz H; Idani A; Eliaderani MK; Peirovi N; Dokhani N; Lotfalizadeh MH; Rezaei MM; Ghahfarokhi MS; KarkonShayan S; Hanjani PN; Kardaan Z; Navashenagh JG; Yousefi M; Abdolahi M; Salmaninejad A
Pathol Res Pract; 2023 Aug; 248():154618. PubMed ID: 37331185
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free Urine.
Fredsøe J; Rasmussen AKI; Thomsen AR; Mouritzen P; Høyer S; Borre M; Ørntoft TF; Sørensen KD
Eur Urol Focus; 2018 Dec; 4(6):825-833. PubMed ID: 28753866
[TBL] [Abstract][Full Text] [Related]
32. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
33. Identification of candidate miRNA biomarkers from miRNA regulatory network with application to prostate cancer.
Zhang W; Zang J; Jing X; Sun Z; Yan W; Yang D; Shen B; Guo F
J Transl Med; 2014 Mar; 12():66. PubMed ID: 24618011
[TBL] [Abstract][Full Text] [Related]
34. Combinations of serum prostate-specific antigen and plasma expression levels of let-7c, miR-30c, miR-141, and miR-375 as potential better diagnostic biomarkers for prostate cancer.
Kachakova D; Mitkova A; Popov E; Popov I; Vlahova A; Dikov T; Christova S; Mitev V; Slavov C; Kaneva R
DNA Cell Biol; 2015 Mar; 34(3):189-200. PubMed ID: 25521481
[TBL] [Abstract][Full Text] [Related]
35. Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer.
McDonald AC; Vira M; Shen J; Sanda M; Raman JD; Liao J; Patil D; Taioli E
Prostate; 2018 May; 78(6):411-418. PubMed ID: 29383739
[TBL] [Abstract][Full Text] [Related]
36. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
37. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
Sun D; Lee YS; Malhotra A; Kim HK; Matecic M; Evans C; Jensen RV; Moskaluk CA; Dutta A
Cancer Res; 2011 Feb; 71(4):1313-24. PubMed ID: 21212412
[TBL] [Abstract][Full Text] [Related]
38. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
[TBL] [Abstract][Full Text] [Related]
39. Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling.
Kristensen H; Thomsen AR; Haldrup C; Dyrskjøt L; Høyer S; Borre M; Mouritzen P; Ørntoft TF; Sørensen KD
Oncotarget; 2016 May; 7(21):30760-71. PubMed ID: 27120795
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
